The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP1300-CMap - NLT_B: Toxicogenomic signatures after exposure to everolimus TSA9828-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus TSA9833-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus TSF14041-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 0.2 µM 1 subfactor(s) TSF14033-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 49.99 µM 1 subfactor(s) TSF14034-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 24.98 µM 1 subfactor(s) TSF14035-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 12.46 µM 1 subfactor(s) TSF14036-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 6.24 µM 1 subfactor(s) TSF14042-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 0.1 µM 1 subfactor(s) TSF14037-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 3.12 µM 1 subfactor(s) TSF14038-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 1.6 µM 1 subfactor(s) TSF14039-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 0.8 µM 1 subfactor(s) TSF14040-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 0.39 µM 1 subfactor(s) TSF14043-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 0.05 µM 1 subfactor(s) TSF14087-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 49.99 µM 1 subfactor(s) TSF14088-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 24.98 µM 1 subfactor(s) TSF14089-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 12.46 µM 1 subfactor(s) TSF14090-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 6.24 µM 1 subfactor(s) TSF14091-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 3.12 µM 1 subfactor(s) TSF14092-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 1.6 µM 1 subfactor(s) TSF14093-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 0.8 µM 1 subfactor(s) TSF14094-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 0.39 µM 1 subfactor(s) TSF14095-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 0.2 µM 1 subfactor(s) TSF14096-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 0.1 µM 1 subfactor(s) TSF14097-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 0.05 µM 1 subfactor(s) TSS14044-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 0.2 µM TSS14036-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 49.99 µM TSS14037-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 24.98 µM TSS14038-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 12.46 µM TSS14039-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 6.24 µM TSS14045-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 0.1 µM TSS14040-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 3.12 µM TSS14041-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 1.6 µM TSS14042-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 0.8 µM TSS14043-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 0.39 µM TSS14046-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to everolimus 0.05 µM TSS14090-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 49.99 µM TSS14091-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 24.98 µM TSS14092-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 12.46 µM TSS14093-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 6.24 µM TSS14094-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 3.12 µM TSS14095-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 1.6 µM TSS14096-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 0.8 µM TSS14097-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 0.39 µM TSS14098-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 0.2 µM TSS14099-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 0.1 µM TSS14100-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to everolimus 0.05 µM
TSP1300 - CMap - NLT_B: Toxicogenomic signatures after exposure to everolimus
Public
https://clue.io/data/NLT#NLT_B
Experimental design
No experimental design provided
Results
No results provided